---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-006311"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2024-11-13T23:59:59+00:00"
generated_at: "2026-05-30T00:52:05.076715+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology Q3 loss of $2.3M; revenue down 49%; exploring strategic alternatives

## Summary
- Loss from continuing ops of ~$2.3M on revenue of $345,686, down from $676,626 YoY.
- EPS loss of $(0.36) vs $(0.68) in Q3 2023; cash fell to $3.1M from $8.7M at year end.
- Board initiated process to evaluate strategic alternatives including sale or licensing to maximize shareholder value.
- Implemented cost savings initiative reducing annualized cash burn by ~20%.
- Raised $1.3M in July via warrant exercise of 958,117 warrants.

## SEC filing metadata
- accession: 0001171843-24-006311
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2024-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184324006311/0001171843-24-006311-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184324006311/f8k_111224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-006311
- JSON: https://secwatch.observer/filing/0001171843-24-006311.json
- Plain text: https://secwatch.observer/filing/0001171843-24-006311.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.